Thrombopoietin Receptor Agonists Plus Immunosuppressive Therapy in Aplastic Anaemia: A Systematic Review and Meta-Analysis [0.03%]
促进血小板生成素受体激动剂与免疫抑制疗法联合治疗再生障碍性贫血的系统评价和 meta 分析
Elham Ashrafi,Lauren Young,Lucy C Fox et al.
Elham Ashrafi et al.
Background: Immunosuppressive therapy (IST) is standard first-line treatment for severe aplastic anaemia (AA) in patients ineligible for allogeneic transplantation. Thrombopoietin receptor agonists (TPO-RAs) are increasin...
Tara Rakiewicz,Neil Palmisiano
Tara Rakiewicz
Background: Advances in genetic testing have allowed for extensive testing and identification of previously unrecognized inherited conditions; a prominent area of this research includes familial patterns of acute myeloid ...
Elranatamab for Treatment of Multiple Myeloma With Central Nervous Involvement Refractory to Other Interventions [0.03%]
用于治疗对其他治疗方法耐药的中枢神经系统受累多发性骨髓瘤的埃尔拉纳单抗疗法
Kelley Julian,Briana Peterson,Ghulam Rehman Mohyuddin
Kelley Julian
Background: Plasma cell leukemia and central nervous system involvement are two poor prognostic factors in myeloma, and such patients are often excluded from clinical trials. ...
Comparative Efficacy of Complement Inhibitors in Complement Inhibitor-Naïve PNH: A Systematic Review With Supportive Exploratory Network Meta-Analysis of Randomized Trials [0.03%]
补体抑制初治PNH患者中补体抑制剂疗效的系统评价和探索性网络meta分析
Rehan Ishaque,Abdul Subhan Talpur,Hafiza Sidra et al.
Rehan Ishaque et al.
Introduction: Paroxysmal nocturnal haemoglobinuria (PNH) is an uncommon, life-threatening disease, caused by intravascular haemolysis by the complement system. In this review, we aim to compare the efficacy of the availab...
Secondary Chronic Myeloid Leukemia in the Blast Phase With Mixed Phenotype After Radiation Therapy: A Case Report [0.03%]
放射治疗后继发混合表型慢性粒细胞白血病急变期一例报告
Masanori Aoki,Tomoya Maeda,Hiromi Kinoshita et al.
Masanori Aoki et al.
A 55-year-old woman underwent hysterectomy and pelvic radiation for cervical cancer, which remains in remission. Forty-three months later, she developed secondary CML-BP with CD19+ mixed phenotype (B/myeloid), previously unreported. Followi...
Understanding Treatment Care and Delays in Acquired Hemophilia A: A Population-Based Study From Nova Scotia, Canada [0.03%]
加拿大Nova Scotia的获得性血友病A治疗护理及延迟的流行病学研究
Rachelle Blackman,Luke Y C Chen,Mary-Margaret Keating et al.
Rachelle Blackman et al.
Objectives: Acquired Hemophilia A (AHA) is a rare, potentially life-threatening bleeding disorder caused by autoantibodies against factor VIII (FVIII). We aimed to characterize patients with AHA in Nova Scotia, Canada, an...
Transition Readiness Assessment Questionnaire: A Tool Associated With Transfer Success for Adolescents and Young Adults Living With Sickle Cell Disease? [0.03%]
转换准备评估问卷:与青少年和青壮年镰状细胞病患者成功过渡相关的工具?
Sophie Marsolais,Yves Pastore,Nancy Robitaille et al.
Sophie Marsolais et al.
Transition from pediatric to adult healthcare is a critical period for adolescents and young adults (AYA) with sickle cell disease (SCD), often associated with increased morbidity. In Canada, healthcare transfer is mandated by Age 18, yet o...
Clinical Profile, Humanistic and Economic Burden of Paroxysmal Nocturnal Hemoglobinuria in Patients Treated With C5 Inhibitors [0.03%]
补体抑制剂治疗阵发性睡眠性血红蛋白尿的临床特征及人文和经济负担
Shreyans Gandhi,Markus P Radsak,Yasutaka Ueda et al.
Shreyans Gandhi et al.
Objectives: To evaluate disease burden among paroxysmal nocturnal hemoglobinuria (PNH) patients prescribed C5 inhibitors (C5i). Methods: ...
A Unique Case of Concomitant T-Prolymphocytic Leukemia and B-Cell Acute Lymphoblastic Leukemia [0.03%]
T-prolymphocytic白血病与B淋巴母细胞白血病/淋巴瘤合并发生的一例临床分析
Viral M Patel,Jonathan Hyak,Soolmaz Laknezhad et al.
Viral M Patel et al.
T-prolymphocytic leukemia (T-PLL) is a rare lymphoid malignancy with a poor prognosis. B-cell acute lymphoblastic leukemia (B-ALL) also confers a poor prognosis, especially in patients with high-risk features without an option for transplan...
Effect of Early Administration of Anti-MRSA Drugs for Febrile Neutropenia in Allogeneic Hematopoietic Cell Transplantation [0.03%]
异基因造血细胞移植后早期应用抗MRSA药物治疗发热性中性粒细胞减少症的疗效分析
Anna Akaogi,Junya Kanda,Fumiya Wada et al.
Anna Akaogi et al.
Background: In febrile neutropenia (FN), the empirical use of anti-methicillin-resistant Staphylococcus aureus (MRSA) drugs is recommended, particularly when mucosal damage occurs during fluoroquinolone antibiotic adminis...